High Percentage of IBD Patients with Indefinite Fecal Calprotectin Levels: Additional Value of a Combination Score
2016 · Digestive Diseases and Sciences · 34 citations
https://doi.org/10.1007/s10620-016-4397-6
T
Tim van den Heuvel
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
95
Papers
1.6K
Citations
20
h-index
27
i10-index
Tim van den Heuvel is an academic researcher from Medtronic (Switzerland). The author has contributed to research in topics: Diabetes Management and Research & Inflammatory Bowel Disease & Microscopic Colitis. The author has an h-index of 20, co-authored 81 publications.
ORCID: 0000-0002-3907-6876Papers by this author
worksRisk Factors and Clinical Outcomes in Patients with IBD with Melanoma
2017 · Inflammatory Bowel Diseases · 20 citations
https://doi.org/10.1097/mib.0000000000001191
Advanced Hybrid Closed Loop Algorithm Use in Type 1 Diabetes: The French MiniMed™ Glycemic Control and Quality of Life Study
2024 · Diabetes Therapy · 2 citations
https://doi.org/10.1007/s13300-024-01673-9
Use of the temporary glycemic target feature in the medtronic MiniMed™ 780G advanced hybrid closed loop system: a real-world evidence study
2025 · Acta Diabetologica · 2 citations
https://doi.org/10.1007/s00592-025-02526-y
Real-World Performance of the MiniMed 780G Advanced Hybrid Closed-Loop System in the Middle East, North Africa, and Türkiye Region
2026 · Diabetes Technology & Therapeutics · 0 citations
https://doi.org/10.1177/15209156251411940
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat